Oxford Immunotec Global PLC (OXFD.OQ)
OXFD.OQ on NASDAQ Stock Exchange Global Market
13.93USD
14 Dec 2018
13.93USD
14 Dec 2018
Change (% chg)
$-0.43 (-2.99%)
$-0.43 (-2.99%)
Prev Close
$14.36
$14.36
Open
$14.27
$14.27
Day's High
$14.40
$14.40
Day's Low
$13.78
$13.78
Volume
31,407
31,407
Avg. Vol
34,414
34,414
52-wk High
$19.10
$19.10
52-wk Low
$10.26
$10.26
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 16.05 | -0.240 |
| Jun '18 | 29.32 | -0.250 | |
| Mar '18 | 21.37 | -0.401 | |
| FY 2017 | Dec '17 | 25.03 | 1.182 |
| Sep '17 | 15.01 | -0.808 | |
| Jun '17 | 26.12 | -0.735 | |
| Mar '17 | 21.50 | -0.358 | |
| FY 2016 | Dec '16 | 23.70 | -0.217 |
| Sep '16 | 26.11 | -0.179 | |
| Jun '16 | 19.15 | -0.288 | |
| Mar '16 | 17.11 | -0.316 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 3 | 14.80 | 15.30 | 14.10 | 30.21 |
| Quarter Ending Mar-19 | 3 | 13.60 | 15.00 | 12.40 | 29.00 |
| Year Ending Dec-18 | 2 | 81.50 | 82.00 | 81.00 | 119.94 |
| Year Ending Dec-19 | 3 | 69.33 | 73.90 | 67.00 | 137.13 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 4 | -0.19 | -0.13 | -0.27 | -0.31 |
| Quarter Ending Mar-19 | 3 | -0.20 | -0.18 | -0.23 | -- |
| Year Ending Dec-18 | 3 | -1.05 | -1.02 | -1.08 | -1.11 |
| Year Ending Dec-19 | 4 | -0.35 | -0.12 | -0.49 | -0.80 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 195.05 | 34.39 | |
| P/E High - Last 5 Yrs. | -- | 74.34 | 46.24 | |
| P/E Low - Last 5 Yrs. | -- | 20.27 | 24.59 | |
| Beta | -0.09 | 0.93 | 0.91 | |
| Price to Sales (TTM) | 4.39 | 8.48 | 6.22 | |
| Price to Book (MRQ) | 7.35 | 4.09 | 5.20 | |
| Price to Tangible Book (MRQ) | 19.50 | 5.49 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 17.97 | 24.17 | |
| % Owned Institutions | 80.78 | 18.32 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.77 | 1.44 | |
| Dividend Yield - 5 Year Avg | -- | 0.65 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 6.36 | 4.94 | |
| Payout Ratio(TTM) | -- | 22.35 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 36.37 | 13.11 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 37.25 | 6.32 | 6.50 | |
| Sales - 5 Yr. Growth Rate | 46.76 | 3.01 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -154.93 | 45.72 | 23.08 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -36.21 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 3.93 | 10.49 | |
| Capital Spending - 5 Yr. Growth Rate | 13.99 | 10.59 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 2.51 | 1.71 | 2.28 |
| Current Ratio (MRQ) | 2.93 | 2.22 | 3.10 |
| LT Debt to Equity (MRQ) | 56.53 | 41.60 | 11.49 |
| Total Debt to Equity (MRQ) | 56.70 | 52.31 | 16.03 |
| Interest Coverage (TTM) | -- | 19.38 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 53.11 | 56.99 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 51.89 | 55.45 | 52.36 | |
| EBITD Margin (TTM) | -21.42 | -- | -- | |
| EBITD - 5 Yr. Avg | -31.65 | 15.59 | 13.16 | |
| Operating Margin (TTM) | -37.10 | -1.06 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | -35.80 | 7.30 | 8.47 | |
| Pre-Tax Margin (TTM) | -40.96 | -0.30 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | -37.26 | 6.47 | 8.71 | |
| Net Profit Margin (TTM) | -34.58 | -2.23 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | -35.89 | 4.44 | 4.91 | |
| Effective Tax Rate (TTM) | -- | 15.97 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 20.76 | 23.83 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 225,553 | 16,212,339 | 873,053,182 | |
| Net Income/Employee (TTM) | -77,991 | 1,434,237 | 103,483,965 | |
| Receivable Turnover (TTM) | 7.02 | 5.51 | 5.80 | |
| Inventory Turnover (TTM) | 5.04 | 4.48 | 3.56 | |
| Asset Turnover (TTM) | 0.94 | 0.79 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -32.62 | 1.29 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | -25.10 | 4.50 | 12.50 | |
| Return on Investment (TTM) | -39.14 | 9.63 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | -29.78 | 6.13 | 16.23 | |
| Return on Equity (TTM) | -50.71 | 15.55 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | -31.92 | 9.64 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 37.11 | 30.44 | 46.76 |
| EPS (TTM) % | 11.03 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Oxford Immunotec Global PLC
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 94.43% |
| # of Holders: | 119 |
| Total Shares Held: | 24,892,393 |
| 3 Mo. Net Change: | 564,633 |
| # New Positions: | 16 |
| # Closed Positions: | 11 |
| # Increased Positions: | 61 |
| # Reduced Positions: | 40 |
| # Net Buyers: | 21 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.